ask="0.450"
ask_size="N/A"
average_daily_volume="N/A"
bid="0.185"
bid_size="N/A"
book_value="0.000"
change="-0.113"
change_from_200_day_moving_average="N/A"
change_from_50_day_moving_average="N/A"
change_from_52_week_high="N/A"
change_From_52_week_low="N/A"
change_in_percent="-25.111%"
close="0.337"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="N/A"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="0.400"
high_52_weeks="N/A"
last_trade_date="1/20/2017"
last_trade_price="0.337"
last_trade_size="100"
last_trade_time="3:52pm"
low="0.300"
low_52_weeks="N/A"
market_capitalization="N/A"
moving_average_200_day="N/A"
moving_average_50_day="N/A"
name="Oncobiologics
Inc. - Series B "
notes="N/A"
one_year_target_price="N/A"
open="0.400"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="N/A"
percent_change_from_50_day_moving_average="N/A"
percent_change_from_52_week_high="N/A"
percent_change_from_52_week_low="N/A"
previous_close="0.450"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="N/A"
stock_exchange="NGM"
symbol="ONSIZ"
volume="7300"
weeks_range_52="N/A"
